ANSYS - FDA - Avicenna
Roundtable Discussion

SAVE THE DATE! Roundtable discussion in Washington on 11 October 2019

 

For those of you who will be in Washington mid-October, ANSYS, in cooperation with the FDA and the Avicenna Alliance, is organizing a roundtable discussion titled "Transforming Computational Modeling from A Valuable Scientific Tool to A Valuable Regulatory Tool: Myth or Reality?". 

 

The goal of the meeting is to discuss opportunities and challenges when utilizing in silico approaches during development and regulatory review.  The event will be organized around 2 panel discussions, where senior leaders from the largest medical device and pharmaceutical companies will be sharing their experience and expectations.

When and where: 11 October 2019, Marriott at Hyattsville Maryland (same hotel as BMES Conference).

 

Please register here to reserve your spot.

Do not hesitate to contact Krista Loeffler at krista.loeffler@ansys.com for more information.

 

The draft agenda is structured as follows:

Avicenna Alliance news

The European Commission has established the European Health and Digital Executive Agency (HaDEA)

On 1 April, the European Commission has newly established the European Health and Digital Executive...

find out more ›

President Biden’s plans to establish HARPA

U.S. President Joe Biden is considering plans to create an Advanced Research Projects Agency for Health (HARPA). This entity would support the funding of...

find out more ›

Avicenna provides input to the European Parliament Special Committee on Beating Cancer

Early March, the Avicenna Alliance had the opportunity to provide the European Parliament’s Committee on...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up